| Trial Identifier: | D781WR00001 |
| Sponsor: | AstraZeneca |
| Start Date: | September 2025 |
| Primary Completion Date: | March 2028 |
| Study Completion Date: | March 2028 |
| Condition: | Anal Cancer; Cancer - Other; Endometriosis; Esophageal cancer; Head and Neck Cancer; Liver Cancer; Skin Cancer; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer; Lung Cancer; Testicular Cancer; Thyroid Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| USA, Alabama | Birmingham, Alabama, USA, 35243 |
| USA, Arizona | Bullhead City, Arizona, USA, 86442 |
| USA, Arizona | Casa Grande, Arizona, USA, 85122 |
| USA, California | San Diego, California, USA, 92123 |
| USA, Colorado | Boulder, Colorado, USA, 80309 |
| USA, Florida | Coral Springs, Florida, USA, 33065 |
| USA, Florida | Saint Petersburg, Florida, USA, 33714 |
| USA, Florida | West Palm Beach, Florida, USA, 33401 |
| USA, Illinois | Decatur, Illinois, USA, 62526 |
| USA, Kansas | Topeka, Kansas, USA, 66604 |
| USA, North Carolina | Durham, North Carolina, USA, 27708 |
| USA, North Carolina | Wilson, North Carolina, USA, 27893 |
| USA, Ohio | Canton, Ohio, USA, 44718 |
| USA, Ohio | Maumee, Ohio, USA, 43537 |
| USA, Pennsylvania | Philadelphia, Pennsylvania, USA, 19104 |
| USA, Tennessee | Nashville, Tennessee, USA, 37203 |
| USA, Texas | Dallas, Texas, USA, 75390 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2026 Pharma Intelligence UK Limited (Citeline), a Norstella company